vs

Side-by-side financial comparison of Organogenesis Holdings Inc. (ORGO) and WINMARK CORP (WINA). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($37.2M vs $21.1M, roughly 1.8× WINMARK CORP). On growth, WINMARK CORP posted the faster year-over-year revenue change (7.9% vs -57.1%). Over the past eight quarters, WINMARK CORP's revenue compounded faster (2.4% CAGR vs -46.5%).

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

Winmark Corporation is an American franchisor of five retail businesses that specialize in buying and selling used goods. The company is based in Minneapolis, Minnesota. Winmark was founded in 1988 as Play It Again Sports Franchise Corporation by Ron Olson and Jeffrey Dahlberg after they purchased the Play It Again Sports franchise rights from Martha Morris. They renamed the company to Grow Biz International Inc. in June 1993. Grow Biz went public in August 1993. In 2000, John Morgan replaced...

ORGO vs WINA — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.8× larger
ORGO
$37.2M
$21.1M
WINA
Growing faster (revenue YoY)
WINA
WINA
+64.9% gap
WINA
7.9%
-57.1%
ORGO
Faster 2-yr revenue CAGR
WINA
WINA
Annualised
WINA
2.4%
-46.5%
ORGO

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ORGO
ORGO
WINA
WINA
Revenue
$37.2M
$21.1M
Net Profit
$10.0M
Gross Margin
30.8%
Operating Margin
-185.1%
61.7%
Net Margin
47.2%
Revenue YoY
-57.1%
7.9%
Net Profit YoY
3.9%
EPS (diluted)
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ORGO
ORGO
WINA
WINA
Q1 26
$37.2M
Q4 25
$225.6M
$21.1M
Q3 25
$150.9M
$22.6M
Q2 25
$101.0M
$20.4M
Q1 25
$86.7M
$21.9M
Q4 24
$126.7M
$19.5M
Q3 24
$115.2M
$21.5M
Q2 24
$130.2M
$20.1M
Net Profit
ORGO
ORGO
WINA
WINA
Q1 26
Q4 25
$43.7M
$10.0M
Q3 25
$21.6M
$11.1M
Q2 25
$-9.4M
$10.6M
Q1 25
$-18.8M
$10.0M
Q4 24
$7.7M
$9.6M
Q3 24
$12.3M
$11.1M
Q2 24
$-17.0M
$10.4M
Gross Margin
ORGO
ORGO
WINA
WINA
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
ORGO
ORGO
WINA
WINA
Q1 26
-185.1%
Q4 25
28.1%
61.7%
Q3 25
13.7%
65.9%
Q2 25
-12.5%
64.0%
Q1 25
-30.9%
62.0%
Q4 24
8.1%
65.3%
Q3 24
5.4%
69.4%
Q2 24
-10.7%
64.7%
Net Margin
ORGO
ORGO
WINA
WINA
Q1 26
Q4 25
19.4%
47.2%
Q3 25
14.3%
49.2%
Q2 25
-9.3%
51.9%
Q1 25
-21.7%
45.4%
Q4 24
6.1%
49.0%
Q3 24
10.7%
51.7%
Q2 24
-13.1%
51.8%
EPS (diluted)
ORGO
ORGO
WINA
WINA
Q1 26
Q4 25
$0.31
$2.68
Q3 25
$0.11
$3.02
Q2 25
$-0.10
$2.89
Q1 25
$-0.17
$2.71
Q4 24
$0.05
$2.60
Q3 24
$0.09
$3.03
Q2 24
$-0.13
$2.85

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ORGO
ORGO
WINA
WINA
Cash + ST InvestmentsLiquidity on hand
$91.4M
$10.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-53.7M
Total Assets
$520.0M
$24.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ORGO
ORGO
WINA
WINA
Q1 26
$91.4M
Q4 25
$93.7M
$10.3M
Q3 25
$63.7M
$39.7M
Q2 25
$73.1M
$28.8M
Q1 25
$110.0M
$21.8M
Q4 24
$135.6M
$12.2M
Q3 24
$94.3M
$37.2M
Q2 24
$89.9M
$29.4M
Total Debt
ORGO
ORGO
WINA
WINA
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
ORGO
ORGO
WINA
WINA
Q1 26
Q4 25
$300.1M
$-53.7M
Q3 25
$255.1M
$-26.3M
Q2 25
$233.2M
$-36.8M
Q1 25
$242.9M
$-45.9M
Q4 24
$262.9M
$-51.0M
Q3 24
$278.5M
$-33.7M
Q2 24
$263.5M
$-42.2M
Total Assets
ORGO
ORGO
WINA
WINA
Q1 26
$520.0M
Q4 25
$598.7M
$24.9M
Q3 25
$509.8M
$53.7M
Q2 25
$461.1M
$43.2M
Q1 25
$467.4M
$37.1M
Q4 24
$497.9M
$26.8M
Q3 24
$446.3M
$52.0M
Q2 24
$443.2M
$44.7M
Debt / Equity
ORGO
ORGO
WINA
WINA
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ORGO
ORGO
WINA
WINA
Operating Cash FlowLast quarter
$8.5M
Free Cash FlowOCF − Capex
$8.5M
FCF MarginFCF / Revenue
40.3%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
0.86×
TTM Free Cash FlowTrailing 4 quarters
$44.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ORGO
ORGO
WINA
WINA
Q1 26
Q4 25
$39.4M
$8.5M
Q3 25
$3.1M
$12.3M
Q2 25
$-32.9M
$9.0M
Q1 25
$-19.9M
$15.1M
Q4 24
$10.9M
$8.5M
Q3 24
$8.7M
$12.1M
Q2 24
$4.7M
$8.2M
Free Cash Flow
ORGO
ORGO
WINA
WINA
Q1 26
Q4 25
$34.8M
$8.5M
Q3 25
$844.0K
$12.2M
Q2 25
$-36.5M
$9.0M
Q1 25
$-23.6M
$15.0M
Q4 24
$7.6M
Q3 24
$6.1M
$12.1M
Q2 24
$2.9M
$8.1M
FCF Margin
ORGO
ORGO
WINA
WINA
Q1 26
Q4 25
15.4%
40.3%
Q3 25
0.6%
53.8%
Q2 25
-36.1%
44.0%
Q1 25
-27.2%
68.6%
Q4 24
6.0%
Q3 24
5.3%
56.3%
Q2 24
2.2%
40.4%
Capex Intensity
ORGO
ORGO
WINA
WINA
Q1 26
Q4 25
2.1%
0.1%
Q3 25
1.5%
0.3%
Q2 25
3.6%
0.3%
Q1 25
4.2%
0.2%
Q4 24
2.7%
0.0%
Q3 24
2.2%
0.0%
Q2 24
1.4%
0.5%
Cash Conversion
ORGO
ORGO
WINA
WINA
Q1 26
Q4 25
0.90×
0.86×
Q3 25
0.14×
1.10×
Q2 25
0.85×
Q1 25
1.51×
Q4 24
1.43×
0.88×
Q3 24
0.71×
1.09×
Q2 24
0.79×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons